Izotropic Corporation

Equities

IZO

CA46604F1099

Advanced Medical Equipment & Technology

Delayed Canadian Securities Exchange Other stock markets 02:46:28 2024-04-17 pm EDT			5-day change	1st Jan Change
0.125 ^CAD	+4.17%		-10.71%	+25.00%

Apr. 02	Izotropic Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	CI
Jan. 30	Izotropic Corporation Receives Response from U.S. FDA	CI

Izotropic : Watch the Izotropic Corporation Presentation at the June 23, 2022 Life Sciences Investor Forum

June 23, 2022

Click on the following link to view the Izotropic Corporation (OTCQB: IZOZF | CSE: IZO) Company Presentation at the Life Sciences Investor Forum hosted by OTC Markets Group and Zacks Small Cap Research on Thursday, June 23, 2022:

Izotropic Corporation (OTCQB: IZOZF | CSE: IZO) Company Presentation

Attachments

Original Link
Original Document
Permalink

Disclaimer

Izotropic Corporation published this content on 24 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 June 2022 09:25:10 UTC.

Latest news about Izotropic Corporation

Izotropic Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	Apr. 02	CI
Izotropic Corporation Receives Response from U.S. FDA	Jan. 30	CI
Izotropic Corporation Provides an Update on its Regulatory Status with the U.S. Food and Drug Administration and Operational Activities	Jan. 08	CI
Izotropic Corporation Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	Dec. 30	CI
Izotropic Corporation Reports Earnings Results for the First Quarter Ended July 31, 2023	23-09-27	CI
Izotropic Corporation Confirms Fda Pre-Submission Meeting Date with U.S. Food and Drug Administration	23-09-27	CI
Izotropic Corporation Files Class II Pre-Submission with FDA & Releases Details on Predicate Devices	23-09-21	CI
Izotropic Corporation announced that it has received CAD 0.710331 million in funding	23-09-19	CI
Izotropic Corporation announced that it expects to receive CAD 0.5 million in funding	23-09-12	CI
Izotropic Corporation Reports Earnings Results for the Full Year Ended April 30, 2023	23-08-29	CI
Izotropic Corporation Announces Resignation of John McGraw as Board of Directors	23-06-08	CI
Izotropic Corporation Announces John McGraw Has Resigned as Chief Executive Officer	23-06-08	CI
Izotropic Corporation Completes Sub Submission with Fda Regarding Clinical Study	23-05-16	CI
Izotropic Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	23-03-30	CI
Izotropic Corporation Announces CFO Changes	23-01-04	CI
Izotropic Corporation Announces Executive Changes	23-01-04	CI
Izotropic Corporation Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	22-12-16	CI
Izotropic Completes IzoView Development and Assembly, Prepares for Final Testing	22-12-01	CI
Izotropic Corporation Appoints Alexander Tokman to Board of Director	22-11-11	CI
Izotropic Corporation announced that it has received CAD 1 million in funding	22-11-09	CI
Izotropic Corporation Reports Earnings Results for the First Quarter Ended July 31, 2022	22-09-28	CI
Izotropic Corporation Reports Earnings Results for the Full Year Ended April 30, 2022	22-08-26	CI
Izotropic Corporation Auditor Raises 'Going Concern' Doubt	22-08-25	CI
Izotropic Corporation Finalizes Engineering and Development Transition to the United States; Establishes Operations in Primary Target Market	22-08-11	CI
Izotropic Corporation Unveils Izoview Commercial Prototype, Files New Patents	22-05-10	CI

Chart Izotropic Corporation

Duration

Period

More charts

Company Profile

Izotropic Corporation is a Canada-based medical device company. The Company is commercializing IzoView, a computed tomography (CT) imaging system, which produces images of anatomy for non-invasive tissue characterization with the first application in breast imaging. The Company has not generated any revenue.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-22 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Imaging Systems

	1st Jan change	Capi.
IZOTROPIC CORPORATION	+25.00%	5M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-11.43%	13.99B
IRAY TECHNOLOGY COMPANY LIMITED	-42.51%	2.73B
SONOSCAPE MEDICAL CORP.	-21.84%	2.23B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-15.46%	1.4B
CORETAG, INC.	-.--%	1.12B
NANO-X IMAGING LTD.	+36.11%	524M
GUERBET	+73.33%	445M
DETECTION TECHNOLOGY OYJ	-2.19%	216M
VIEWORKS CO., LTD.	+1.11%	182M

Medical Imaging Systems